Stephen Stripling, MD, FAAP, Discusses Study of Berdazimer Gel for Molluscum Contagiosum

With no current FDA-approved treatments for molluscum contagiosum, Stephen Stripling, MD, FAAP, and co-medical director at Coastal Pediatric Research in Charleston, South Carolina, explains the importance of the JAMA berdazimer gel 10.3% study¹ and the hope it provides for patients and their families.

Reference:

1. Browning JC, Enloe C, Cartwright M, et al. Efficacy and Safety of Topical Nitric Oxide−Releasing Berdazimer Gel in Patients With Molluscum Contagiosum: A Phase 3 Randomized Clinical Trial. JAMA Dermatol. Published online July 13, 2022. doi:10.1001/jamadermatol.2022.2721